Several studies highlight novel small-molecule NLRP3 inhibitors, such as Dapansutrile (OLT1177TM), MCC950, and cucurbitacin B, which effectively reduce MSU-induced inflammation in experimental gout models [19,20]. This evidence concerns the gene NLRP3 and gout.